Skip to main content
Fig. 3 | Trials

Fig. 3

From: A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study

Fig. 3

Sensitivity of the sample size for the co-primary endpoint CAP-related change in patient care status with regard to the non-inferiority margin, \({\delta }_{\text{ARD}}\), expecting no difference between placebo and azithromycin (absolute risk difference = 0), assuming a probability for a change in patient care status of 0.05

Back to article page

Trials

ISSN: 1745-6215